glp-1-directed nmda receptor antagonism for obesity treatment GLP-1 Agonists and Research to Treat Overeating and Substance Use Disorders GLP1 Receptor Agonists—Effects beyond Obesity

Gut microbiomes of Malawian twin pairs discordant for kwashiorkor

Back Randle, PJ (29 May 1954) 'Assay of plasma insulin activity by the rat-diaphragm method', British Medical Journal , 1, 1237-40

Each of these involves different mechanisms, different prognoses, and different treatment approaches, which is why understanding which type you are dealing with matters enormously for your safety and treatment planning

This innovation contests the conventional dependence on injectable formulations and has the potential to enhance patient acceptability and adherence

Glucagon-Like Peptide-1

10.1093/ajcn/nqaa015 30 GallwitzB